230 related articles for article (PubMed ID: 32257760)
1. Complete response of renal cell carcinoma with an inferior vena cava tumor thrombus and lung metastases after treatment with nivolumab plus ipilimumab.
Okada T; Hamamoto S; Etani T; Naiki T; Sue Y; Banno R; Yamada K; Sakakura T; Yasui T
Int Cancer Conf J; 2020 Apr; 9(2):88-91. PubMed ID: 32257760
[TBL] [Abstract][Full Text] [Related]
2. Complete response of metastatic renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus ipilimumab.
Hayashida M; Miura Y; Noda T; Yamanaka T; Tanaka N; Yasuoka S; Oka S; Sakaguchi K; Kinowaki K; Urakami S
IJU Case Rep; 2022 Jul; 5(4):268-272. PubMed ID: 35795114
[TBL] [Abstract][Full Text] [Related]
3. Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy.
Labbate C; Hatogai K; Werntz R; Stadler WM; Steinberg GD; Eggener S; Sweis RF
J Immunother Cancer; 2019 Mar; 7(1):66. PubMed ID: 30857555
[TBL] [Abstract][Full Text] [Related]
4. Sarcomatoid renal cell carcinoma with an inferior vena cava tumor thrombus that was completely resected by robot-assisted laparoscopic radical nephrectomy after neoadjuvant therapy nivolumab plus ipilimumab: a case report.
Tsuchiyama A; Ohba K; Nakanishi H; Yasuda T; Nakamura Y; Kurohama H; Mitsunari K; Matsuo T; Mochizuki Y; Imamura R
Int Cancer Conf J; 2024 Jan; 13(1):6-10. PubMed ID: 38187173
[TBL] [Abstract][Full Text] [Related]
5. Complete response of metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus cabozantinib.
Hayashida M; Miura Y; Yamaguchi T; Tanaka M; Yamanaka T; Takemura K; Oka S; Sakaguchi K; Ito S; Urakami S
IJU Case Rep; 2023 Nov; 6(6):419-423. PubMed ID: 37928303
[TBL] [Abstract][Full Text] [Related]
6. Preoperative ipilimumab/nivolumab combination therapy reduced operation risk by downstaging the inferior vena cava tumor thrombus extending to the right atrium in a metastatic renal cell carcinoma: A case report.
Otsuka H; Masui K; Hosomi T; Makino Y; Shibasaki N; Shichiri Y
Urol Case Rep; 2022 Jan; 40():101912. PubMed ID: 34777999
[TBL] [Abstract][Full Text] [Related]
7. Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report.
Miyauchi Y; Naito H; Tsunemori H; Tani R; Hasui Y; Miyake Y; Minamino T; Ishikawa R; Kushida Y; Haba R; Sugimoto M
J Med Case Rep; 2021 Oct; 15(1):508. PubMed ID: 34649593
[TBL] [Abstract][Full Text] [Related]
8. Pathological Complete Response to Preoperative Nivolumab Plus Cabozantinib for Renal Cell Carcinoma With Inferior Vena Cava Thrombus: A Case Report.
Machida A; Ikarashi D; Yanagawa N; Suzuki M; Kawamura T; Sekiguchi K; Takahashi K; Kato R; Matsura T; Maekawa S; Kanehira M; Takata R; Sugai T; Obara W
Cancer Diagn Progn; 2023; 3(1):124-129. PubMed ID: 36632579
[TBL] [Abstract][Full Text] [Related]
9. Cine magnetic resonance imaging predicts thrombus adhesion in metastatic renal cell carcinoma with an inferior vena cava tumor thrombus: A case of pathological complete response with pembrolizumab plus lenvatinib.
Hara T; Furukawa J; Tsutiya T; Kodama T; Uehara K; Terakawa T; Harada K; Teishima J; Nakano Y; Fujisawa M
IJU Case Rep; 2024 Jan; 7(1):60-63. PubMed ID: 38173458
[TBL] [Abstract][Full Text] [Related]
10. [Complete Remission of Metastatic Renal Cell Carcinoma with Invasion of the Duodenum and Pancreas after Treatment with Nivolumab Plus Ipilimumab Followed by Axitinib and Surgery : A Case Report].
Hagimoto H; Yamazaki T; Kashima S; Yoshino T; Goto T; Sano T; Sawada A; Akamatsu S; Kobayashi T; Nakano K; Yagi S; Matsuoka Y; Fujimoto M; Kitamura T; Ogawa O
Hinyokika Kiyo; 2021 May; 67(5):197-203. PubMed ID: 34126663
[TBL] [Abstract][Full Text] [Related]
11. Transabdominal two-cavity approach for radical nephrectomy combined with inferior vena cava thrombectomy for malignant thrombus caused by renal cell carcinoma: a case series.
Novotny R; Chlupac J; Marada T; Borovicka V; Vik V; Voska L; Janousek L; Fronek J
J Med Case Rep; 2018 Oct; 12(1):313. PubMed ID: 30355283
[TBL] [Abstract][Full Text] [Related]
12. A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma.
Studentova H; Zemankova A; Spisarova M; Skanderova D; Tudos Z; Melichar B; Student V
Medicina (Kaunas); 2022 Feb; 58(3):. PubMed ID: 35334512
[No Abstract] [Full Text] [Related]
13. Radical Nephrectomy and Pulmonary Lobectomy for Renal Cell Carcinoma With Tumor Thrombus Extension into the Inferior Vena Cava and Pulmonary Arteries.
Manoharan A; Lugo-Baruqui A; Ciancio G
Anticancer Res; 2020 Oct; 40(10):5837-5844. PubMed ID: 32988913
[TBL] [Abstract][Full Text] [Related]
14. [DEFERRED NEPHRECTOMY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA AFTER A NEAR-COMPLETE RESPONSE TO IMMUNOTHERAPY].
Purim O; Raz O; Eisner A; Baram N; Leonov Polak M; Rybo L
Harefuah; 2022 Dec; 161(12):763-768. PubMed ID: 36916116
[TBL] [Abstract][Full Text] [Related]
15. Remarkable effect of presurgical nivolumab on originally inoperable papillary renal cell carcinoma with tumor thrombus in inferior vena cava.
Shinagawa T; Ito H; Sakai Y; Mikami S; Oe H; Taga M; Yokoyama O
Int Cancer Conf J; 2019 Oct; 8(4):170-174. PubMed ID: 31559117
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus.
Nesbitt JC; Soltero ER; Dinney CP; Walsh GL; Schrump DS; Swanson DA; Pisters LL; Willis KD; Putnam JB
Ann Thorac Surg; 1997 Jun; 63(6):1592-600. PubMed ID: 9205155
[TBL] [Abstract][Full Text] [Related]
17. Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinoma.
George G; Schmidt L; Tolat P; Riese M; Kilari D
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32114501
[TBL] [Abstract][Full Text] [Related]
18. Safe administration of ipilimumab plus nivolumab to a dialysis patient with renal cell carcinoma.
Iwaki T; Niimi A; Kano M; Kurokawa Y; Yoshizaki U; Nozaki K; Nomiya A; Miyazaki H; Kume H
IJU Case Rep; 2021 Jan; 4(1):32-35. PubMed ID: 33426493
[TBL] [Abstract][Full Text] [Related]
19. Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports.
Liu SR; Yan Q; Lin HM; Shi GZ; Cao Y; Zeng H; Liu C; Zhang R
World J Clin Cases; 2021 Jul; 9(21):5988-5998. PubMed ID: 34368318
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Metastatic Renal Cell Carcinoma with Arthritis and Colitis Due to Immune-Related Adverse Events During Ipilimumab-Nivolumab Combination Therapy].
Toyoshima M; Ikarashi D; Tsuboi H; Moriwaka M; Tamada S; Matsuura T; Maekawa S; Kato R; Kanehira M; Takata R; Sugimura J; Obara W
Hinyokika Kiyo; 2023 Aug; 69(8):227-232. PubMed ID: 37667600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
